O'Brien Stephen Paul reported TVRD

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002064889-25-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 16, 2025

Published

Dec 18, 2025

Ingested by INSIDER

Nov 5, 04:26 UTC

Last re-read

Nov 5, 04:26 UTC

Extracted facts

Filer

O'Brien Stephen Paul

Role

Principal Accounting Officer

Transaction

Grant or awardAs filed: “A”

Asset

Tvardi Therapeutics, Inc. — Employee Stock Option (right to buy)

Ticker

TVRD

Shares

4,000

Price per share

$0

Execution date (reported)

Dec 16, 2025

Owned after transaction

4,000 shares

Days from execution to publication

2

What this establishes

O'Brien Stephen Paul filed this Form 4 reporting a grant or award of TVRD on Dec 16, 2025. It became public on Dec 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Principal Accounting Officer

O'Brien Stephen Paulcik:0002064889

Issuer

Tvardi Therapeutics, Inc.cik:0001346830

Revision history · 0

No field has changed since this record was first ingested.